Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (71-80 of 203) with videos related to

Pageof 21
Sort By:
Molecular Endocrinology (Baltimore, Md.)|September 1, 1993
Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BPK Morohashi, U M Zanger, S Honda, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type IIU M Zanger, H P Hauri, J Loeper, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemiaRyoichi Fujiwara, Mathias Haag, Elke Schaeffeler, et al.
Pharmacogenetics|October 19, 2000
Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6S Raimundo, J Fischer, M Eichelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: a retrospective exploratory study with long-term follow-upP Fritz, T E Mürdter, M Eichelbaum, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 21, 2018
The azole fungicide tebuconazole affects human CYP1A1 and CYP1A2 expression by an aryl hydrocarbon receptor-dependent pathwayConstanze Knebel, Tanja Heise, Ulrich M Zanger, et al.
Pharmacogenomics|July 20, 2007
Polymorphic CYP2B6: molecular mechanisms and emerging clinical significanceUlrich M Zanger, Kathrin Klein, Tanja Saussele, et al.
Clinical Chemistry|November 4, 2006
MALDI-TOF mass spectrometry for multiplex genotyping of CYP2B6 single-nucleotide polymorphismsJulia K Blievernicht, Elke Schaeffeler, Kathrin Klein, et al.
Leukemia|July 2, 2003
A novel TPMT missense mutation associated with TPMT deficiency in a 5-year-old boy with ALLE Schaeffeler, M Stanulla, J Greil, et al.
Clinical Pharmacology and Therapeutics|November 23, 2006
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepineMikael Oscarson, Ulrich M Zanger, Oktay F Rifki, et al.
Pageof 21

Showing results (71-80 of 203) with videos related to

Sort By:
Pageof 21
Molecular Endocrinology (Baltimore, Md.)|September 1, 1993
Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BPK Morohashi, U M Zanger, S Honda, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type IIU M Zanger, H P Hauri, J Loeper, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemiaRyoichi Fujiwara, Mathias Haag, Elke Schaeffeler, et al.
Pharmacogenetics|October 19, 2000
Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6S Raimundo, J Fischer, M Eichelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: a retrospective exploratory study with long-term follow-upP Fritz, T E Mürdter, M Eichelbaum, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 21, 2018
The azole fungicide tebuconazole affects human CYP1A1 and CYP1A2 expression by an aryl hydrocarbon receptor-dependent pathwayConstanze Knebel, Tanja Heise, Ulrich M Zanger, et al.
Pharmacogenomics|July 20, 2007
Polymorphic CYP2B6: molecular mechanisms and emerging clinical significanceUlrich M Zanger, Kathrin Klein, Tanja Saussele, et al.
Clinical Chemistry|November 4, 2006
MALDI-TOF mass spectrometry for multiplex genotyping of CYP2B6 single-nucleotide polymorphismsJulia K Blievernicht, Elke Schaeffeler, Kathrin Klein, et al.
Leukemia|July 2, 2003
A novel TPMT missense mutation associated with TPMT deficiency in a 5-year-old boy with ALLE Schaeffeler, M Stanulla, J Greil, et al.
Clinical Pharmacology and Therapeutics|November 23, 2006
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepineMikael Oscarson, Ulrich M Zanger, Oktay F Rifki, et al.
Pageof 21